ATE215542T1 - Acridonderivate und verfahren zur herstellung von 8-hydroxyimidazoacridinonderivaten - Google Patents

Acridonderivate und verfahren zur herstellung von 8-hydroxyimidazoacridinonderivaten

Info

Publication number
ATE215542T1
ATE215542T1 AT97939096T AT97939096T ATE215542T1 AT E215542 T1 ATE215542 T1 AT E215542T1 AT 97939096 T AT97939096 T AT 97939096T AT 97939096 T AT97939096 T AT 97939096T AT E215542 T1 ATE215542 T1 AT E215542T1
Authority
AT
Austria
Prior art keywords
dialkylamino
omega
derivatives
formula
hydroxy
Prior art date
Application number
AT97939096T
Other languages
English (en)
Inventor
Jerzy Kazimierz Konopa
Marek Tadeusz Konieczny
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of ATE215542T1 publication Critical patent/ATE215542T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97939096T 1996-10-07 1997-09-10 Acridonderivate und verfahren zur herstellung von 8-hydroxyimidazoacridinonderivaten ATE215542T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9620751A GB2317888A (en) 1996-10-07 1996-10-07 Acridone derivatives and preparation of 8-hydroxy-imidazoacridinone derivatives
PCT/GB1997/002470 WO1998015554A1 (en) 1996-10-07 1997-09-10 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives

Publications (1)

Publication Number Publication Date
ATE215542T1 true ATE215542T1 (de) 2002-04-15

Family

ID=10800965

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97939096T ATE215542T1 (de) 1996-10-07 1997-09-10 Acridonderivate und verfahren zur herstellung von 8-hydroxyimidazoacridinonderivaten

Country Status (11)

Country Link
US (1) US6229015B1 (de)
EP (1) EP0929552B1 (de)
JP (1) JP4138883B2 (de)
AT (1) ATE215542T1 (de)
CA (1) CA2268157C (de)
DE (1) DE69711654T2 (de)
DK (1) DK0929552T3 (de)
ES (1) ES2171993T3 (de)
GB (1) GB2317888A (de)
WO (1) WO1998015554A1 (de)
ZA (1) ZA978960B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070110046A (ko) * 2005-01-28 2007-11-15 크산투스 파마슈티컬스, 인코포레이티드 염증 및 탈수초성 질환을 치료하기 위한 화합물
WO2007092436A2 (en) * 2006-02-08 2007-08-16 Xanthus Pharmaceuticals, Inc. Compounds for treating inflammatory disorders, demyelinating disorders and cancers
US20080108641A1 (en) * 2006-02-08 2008-05-08 Ajami Alfred M Compounds for treating inflammatory disorders, demyelinating disdorders and cancers
PL3070078T3 (pl) 2015-03-20 2018-02-28 Politechnika Gdańska Niesymetryczne bisakrydyny o działaniu przeciwnowotworowym i ich zastosowania

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104548D0 (en) * 1991-03-05 1991-04-17 Cholody Wienlaw M Antineoplastic modified imidazoacridines

Also Published As

Publication number Publication date
JP2001516339A (ja) 2001-09-25
CA2268157C (en) 2006-01-10
US6229015B1 (en) 2001-05-08
ZA978960B (en) 1999-04-07
DE69711654T2 (de) 2002-09-19
WO1998015554A1 (en) 1998-04-16
DK0929552T3 (da) 2002-07-22
CA2268157A1 (en) 1998-04-16
GB9620751D0 (en) 1996-11-20
EP0929552B1 (de) 2002-04-03
GB2317888A (en) 1998-04-08
EP0929552A1 (de) 1999-07-21
JP4138883B2 (ja) 2008-08-27
ES2171993T3 (es) 2002-09-16
DE69711654D1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
DE3680800D1 (de) Verfahren zur herstellung von (6r)-tetrahydro-l-biopterin.
NZ509798A (en) Process for preparing omeprazole
ATE236919T1 (de) Vefahren zur herstellung von erythrmycinderivate
AR247402A1 (es) Un procedimiento para preparar antibioticos macrolidos c-20 aminosustituidos
ATE229022T1 (de) 9-amino und 9-nitrocamptothecinderivate, verfahren zu ihrer herstellung unf ihre verwendung als antitumormittel
AT379800B (de) Verfahren zur herstellung von neuen 2-oxazetidin-derivaten
ATE215542T1 (de) Acridonderivate und verfahren zur herstellung von 8-hydroxyimidazoacridinonderivaten
EP0134984B1 (de) Neue Benzazepin- und Benzoxazepinderivate
EP0197390B1 (de) Herstellung von N-Acetyl-serotonin und Melatonin
ATE259794T1 (de) Verfahren zur herstellung von 3-hydroxy- tetrahydrofuran
AR007291A1 (es) Nuevos derivados de 10,11-dihidro-10-oxo-5h-dibenz/b, f/azepina-5-carboxamida, metodo de preparacion y su uso en la preparacion de una composicion farmaceutica
IL138289A0 (en) Process for the production of purine derivatives
ATE478851T1 (de) Verfahren zur herstellung von 1-substituierten 5- hydroxypyrazolen
DE3761139D1 (de) Verfahren zur herstellung von 4-formyltetrahydropyranen und neue 4-formyltetrahydropyrane.
DE69731941D1 (de) Verfahren zur erzeugung optisch aktiver cyanohydrine
SU135083A1 (ru) Способ дегидрировани 3,4-дигидроизохинолина и его производных
HUT48566A (en) Process for production of dien-1-ols
JPS57109789A (en) 1,2,3,4-tetrahydropyrazino(1,2-a)benzimidazole derivative
ZA200110167B (en) Method for producing condensation compounds.
EP1184381A4 (de) Verfahren zur herstellung von 2,3-dihydrothiepin-derivaten
GB915487A (en) A process for the manufacture of vitamins of the b-group and analogues thereof
Wang Preferential amination of 2, 6-dichloropurine
CZ287080B6 (cs) Způsob přípravy 9,10-dihydroergopeptinů
GB642346A (en) A process for the manufacture of heterocyclic bases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee